These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 5948624)

  • 1. Mammary gland development after hypophysial isografts in intact mice of high and low mammary cancer strains.
    Bardin CW; Liebelt AG; Liebelt RA
    J Natl Cancer Inst; 1966 Feb; 36(2):259-75. PubMed ID: 5948624
    [No Abstract]   [Full Text] [Related]  

  • 2. Systemic effects of hypophysial isografts in female inbred mice.
    Briggs RL; Liebelt AG; Liebelt RA
    J Natl Cancer Inst; 1968 Jun; 40(6):1227-44. PubMed ID: 5690733
    [No Abstract]   [Full Text] [Related]  

  • 3. Mammary carcinogenesis in (C3H X RIII) F1 mice under different experimental conditions.
    Guggiari M; Rudali G
    Biomedicine; 1977 Jan; 27(1):27-31. PubMed ID: 851565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pregnancy, lactation, and pituitary isografts on the genesis of spontaneous mammary gland tumors in the mouse.
    Bruni JE; Montemurro DG
    Cancer Res; 1971 Dec; 31(12):1903-7. PubMed ID: 5120288
    [No Abstract]   [Full Text] [Related]  

  • 5. Site of genetic regulation on hypophysial graft-induced mammary gland development.
    Bardin CW; Liebelt AG; Liebelt RA
    J Natl Cancer Inst; 1968 Dec; 41(6):1453-61. PubMed ID: 4302578
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhancement by pituitary isografts of mammary hyperplastic nodules in adreno-ovariectomized mice.
    Yanai R; Nagasawa H
    J Natl Cancer Inst; 1971 Jun; 46(6):1251-5. PubMed ID: 5088047
    [No Abstract]   [Full Text] [Related]  

  • 7. The incidence of cancer in quantitatively transplanted mammary glands and its relation to age and milk agent of the donor and host mice.
    Hoshino K; Gardner WU; Pawlikowski RA
    Cancer Res; 1965 Nov; 25(10):1792-803. PubMed ID: 4285689
    [No Abstract]   [Full Text] [Related]  

  • 8. Mouse strain (STS/A) resistant to mammary tumor induction by hypophysial isografts.
    van der Gugten AA; Röpcke G; van Nie R; Hilgers J
    Cancer Res; 1985 Aug; 45(8):3448-53. PubMed ID: 4016729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin gene-disruption arrests mammary gland development and retards T-antigen-induced tumor growth.
    Vomachka AJ; Pratt SL; Lockefeer JA; Horseman ND
    Oncogene; 2000 Feb; 19(8):1077-84. PubMed ID: 10713693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent studies on functions and control of prolactin secretion in rats.
    Meites J; Lu KH; Wuttke W; Welsch CW; Nagasawa H; Quadri SK
    Recent Prog Horm Res; 1972; 28():471-526. PubMed ID: 4569231
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of mammary tumorigenesis by ergot alkaloids and promotion of mammary tumorigenesis by pituitary isografts in adreno-ovariectomized mice.
    Yanai R; Nagasawa H
    J Natl Cancer Inst; 1972 Mar; 48(3):715-9. PubMed ID: 5058970
    [No Abstract]   [Full Text] [Related]  

  • 12. Nodule bioassay of the mouse mammary tumor virus: modifications and quantitative considerations.
    Nandi S; Haslam S; Helmich C; Ritter RI
    J Natl Cancer Inst; 1971 Jun; 46(6):1309-15. PubMed ID: 4325935
    [No Abstract]   [Full Text] [Related]  

  • 13. The developmental, noduligenic, and tumorigenic potentials of transplanted mammary glands and primary ducts from C3H mice previously fed a phenylalanine-deficient diet.
    Hui YH; DeOme KB; Briggs GM
    Cancer Res; 1972 Jan; 32(1):57-60. PubMed ID: 5007688
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of pituitary-induced nodular hyperplasia in mammary glands of C3H mice fed a phenylalanine-deficient diet.
    Hui YH; DeOme KB; Briggs GM
    J Natl Cancer Inst; 1971 May; 46(5):929-39. PubMed ID: 4333726
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of the development of the mammary glands of mice with a bromotriphenylethylene.
    Rendon AM; Rudali G; Guggiari M
    Biomedicine; 1978 Nov; 29(8):276-9. PubMed ID: 743562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of mammary tissues of different strains of mice to tumor development.
    Dux A; Mühlbock O
    J Natl Cancer Inst; 1968 Jun; 40(6):1259-72. PubMed ID: 4298251
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on hypophyseal isografts in mice. I. Biologic aspects.
    Boot LM; Röpcke G
    Cancer Res; 1966 Jul; 26(7):1492-6. PubMed ID: 5911591
    [No Abstract]   [Full Text] [Related]  

  • 18. Difference in mammary gland susceptibility to prolactin between a high and a low mammary tumor strains of mice.
    Nagasawa H; Yanai R; Iwahashi H; Fujimoto M; Kuretani K
    Endocrinol Jpn; 1967 Dec; 14(4):351-6. PubMed ID: 5631359
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of dietary phenylalanine deficiency on the mammary tumor virus activity in C3H mice.
    Hui YH; DeOme KB; Briggs GM
    Cancer Res; 1972 Oct; 32(10):2086-8. PubMed ID: 4343007
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of hormone stimulation, dose, and time of administration of carcinogen on carcinogen-induced mammary tumors from preneoplastic nodule outgrowths.
    Medina D
    J Natl Cancer Inst; 1971 Apr; 46(4):909-16. PubMed ID: 5573775
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.